Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Current Neurology and Neuroscience Reports
|
August 21, 2008
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Dennis Bourdette, Vijayshree Yadav
Current Neurology and Neuroscience Reports
|
August 12, 2009
Alemtuzumab versus interferon beta-1a in early multiple sclerosis
Dennis Bourdette, Vijayshree Yadav
Current Neurology and Neuroscience Reports
|
June 25, 2010
Oral disease-modifying therapies for multiple sclerosis: are we there yet?
Vijayshree Yadav, Dennis Bourdette
Current Neurology and Neuroscience Reports
|
July 5, 2012
New disease-modifying therapies and new challenges for MS
Vijayshree Yadav, Dennis Bourdette
Clinical Therapeutics
|
December 4, 2014
Complementary and alternative medical therapies in multiple sclerosis--the American Academy of Neurology guidelines: a commentary
Vijayshree Yadav, Pushpa Narayanaswami
Neurology
|
January 29, 2011
The radiologically isolated syndrome revisited: when is it presymptomatic multiple sclerosis?
Dennis Bourdette, Vijayshree Yadav
Current Neurology and Neuroscience Reports
|
April 26, 2006
Complementary and alternative medicine: is there a role in multiple sclerosis?
Vijayshree Yadav, Dennis Bourdette
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 27, 2012
Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: no
Dennis Bourdette, Vijayshree Yadav
Current Neurology and Neuroscience Reports
|
August 2, 2011
Cognitive impairment and MS: searching for effective therapies
Vijayshree Yadav, Dennis N Bourdette
Expert Review of Clinical Immunology
|
May 6, 2010
Complementary and alternative medicine for the treatment of multiple sclerosis
Vijayshree Yadav, Lynne Shinto, Dennis Bourdette
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Current Neurology and Neuroscience Reports
|
August 21, 2008
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Dennis Bourdette, Vijayshree Yadav
Current Neurology and Neuroscience Reports
|
August 12, 2009
Alemtuzumab versus interferon beta-1a in early multiple sclerosis
Dennis Bourdette, Vijayshree Yadav
Current Neurology and Neuroscience Reports
|
June 25, 2010
Oral disease-modifying therapies for multiple sclerosis: are we there yet?
Vijayshree Yadav, Dennis Bourdette
Current Neurology and Neuroscience Reports
|
July 5, 2012
New disease-modifying therapies and new challenges for MS
Vijayshree Yadav, Dennis Bourdette
Clinical Therapeutics
|
December 4, 2014
Complementary and alternative medical therapies in multiple sclerosis--the American Academy of Neurology guidelines: a commentary
Vijayshree Yadav, Pushpa Narayanaswami
Neurology
|
January 29, 2011
The radiologically isolated syndrome revisited: when is it presymptomatic multiple sclerosis?
Dennis Bourdette, Vijayshree Yadav
Current Neurology and Neuroscience Reports
|
April 26, 2006
Complementary and alternative medicine: is there a role in multiple sclerosis?
Vijayshree Yadav, Dennis Bourdette
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 27, 2012
Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: no
Dennis Bourdette, Vijayshree Yadav
Current Neurology and Neuroscience Reports
|
August 2, 2011
Cognitive impairment and MS: searching for effective therapies
Vijayshree Yadav, Dennis N Bourdette
Expert Review of Clinical Immunology
|
May 6, 2010
Complementary and alternative medicine for the treatment of multiple sclerosis
Vijayshree Yadav, Lynne Shinto, Dennis Bourdette
Page
of 5